Quoin Pharmaceuticals Ltd. (QNRX)

Name: Quoin Pharmaceuticals Ltd. (QNRX) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Quoin Pharmaceuticals Ltd. (QNRX)

Stock Card

$6.71

$0.20 (3.08%)

As on 02-Sep-2026 13:37EDT

Market cap

$12 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

P/B Ratio

2.6

Div. Yield

0 %

Quoin Pharmaceuticals (QNRX) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 6.47 High: 6.97

52 Week Range

Low: 3.25 High: 41.80

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-5.8 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

-0.4
Debt to Equity

0
Book Value

$--
EPS

$-14.9
Face value

--
Shares outstanding

2,008,418

8 Years Aggregate

CFO

$-36.11 Mln

EBITDA

$-0.94 Mln

Net Profit

$11.02 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Quoin Pharmaceuticals (QNRX)	-53.5	50.8	40.7	-9.0	-68.0	-91.2	-74.4
BSE Sensex	-9.6	-2.0	3.1	-4.7	5.4	6.0	10.4
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 02-Sep-2026 | #As on 26-Oct-2023

Company	2025	2024	2023	2022
Quoin Pharmaceuticals (QNRX)	-36.6	-86.5	-71.2	-93.8
S&P Small-Cap 600	4.0	7.0	13.9	-17.4
BSE Sensex	9.1	8.1	18.7	4.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Quoin Pharmaceuticals (QNRX)	6.7	12.3	0.0	-18.8	--	-220	--	2.6
Arrowhead Pharmaceuticals (ARWR)	83.2	11,993.9	669.5	-320.0	-0.8	-71.1	--	26.9
Ascendis Pharma A/S - ADR	265.8	16,261.1	1,054.4	755.9	5.7	--	19	9.8
Cytokinetics Inc (CYTK)	70.9	10,022.2	71.0	-894.0	-1,175.8	--	--	60.3
Exelixis (EXEL)	57.8	13,491.7	2,435.9	860.6	31.0	43	17.4	7.4
Halozyme Therapeutics (HALO)	108.7	11,957.0	1,663.7	413.6	36.3	430	30.9	84.5
Krystal Biotech (KRYS)	365.5	10,402.8	440.5	241.5	33.4	18.7	44.1	7.8
Madrigal Pharmaceuticals (MDGL)	541.9	12,332.1	1,283.9	-325.1	-19.0	-57.7	--	24.0
Medpace Holdings (MEDP)	586.1	16,765.1	2,782.3	491.5	21.1	110.1	35.2	39.3
Praxis Precision MedicinesÂ Inc (PRAX)	355.6	9,625.4	0.0	-339.1	--	-30.6	--	7.6

Shareholding Pattern

View Details

About Quoin Pharmaceuticals (QNRX)

Quoin Pharmaceuticals, Ltd., a late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical... lotion, which is in phase 2 to treat netherton syndrome (NS); phase 1 in to treat peeling skin syndrome; and in pre-clinical stage to treat SAM syndrome and ichthyosis. It also develops QRX008 for the treatment of scleroderma, which is in pre-clinical stage; and QRX009, to treat microcystic lymphatic malformations, venous malformations, angiofibroma, and other diseases. It has a research agreement with Queensland University of Technology. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc. Read more

Co-Founder, CEO & Chairman

Dr. Michael Myers Ph.D.
Co-Founder, CEO & Chairman

Dr. Michael Myers Ph.D.
Headquarters

Ashburn, VA
Website

https://quoinpharma.com

FAQs for Quoin Pharmaceuticals (QNRX)

What is the current share price of Quoin Pharmaceuticals Ltd (QNRX) Today?

The share price of Quoin Pharmaceuticals Ltd (QNRX) is $6.71 (NASDAQ) as of 02-Sep-2026 13:37 EDT. Quoin Pharmaceuticals Ltd (QNRX) has given a return of -67.95% in the last 3 years.

What is the current PB & PE ratio of Quoin Pharmaceuticals Ltd (QNRX)?

Since, TTM earnings of Quoin Pharmaceuticals Ltd (QNRX) is negative, P/E ratio is not available.
The P/B ratio of Quoin Pharmaceuticals Ltd (QNRX) is 2.63 times as on 28-Aug-2026, a 49 discount to its peers’ median range of 5.18 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2025	-1.37	1.65
2024	-0.01	0.01
2023	-0.02	0.02
2022	0.00	0.00
2021	--	--

What is the 52 Week High and Low of Quoin Pharmaceuticals Ltd (QNRX)?

The 52-week high and low of Quoin Pharmaceuticals Ltd (QNRX) are Rs 41.80 and Rs 3.25 as of 03-Sep-2026.

What is the market cap of Quoin Pharmaceuticals Ltd (QNRX)?

Quoin Pharmaceuticals Ltd (QNRX) has a market capitalisation of $ 12 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.

Should I invest in Quoin Pharmaceuticals Ltd (QNRX)?

Before investing in Quoin Pharmaceuticals Ltd (QNRX), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.